Introduction
Decay-accelerating factor (DAF)' of human erythrocytes (E) is a 70-75-kD surface protein which interacts with autologous C4b and C3b fragments when they become attached to the E membrane. By blocking uptake of the second component of complement (C), C2, and factor B, DAF inhibits assembly of the classical as well as the alternative pathway C3 and C5 convertases and thus interferes with the amplification steps of the complement cascade (1) (2) (3) . DAF thereby prevents hemolytic activity from developing at sites where small numbers of C3b or C4b molecules become attached either directly to E, or indirectly to cells that are "bystanders" to the source of complement activation. Because DAF does not inhibit convertase formation on 1. Abbreviations used in this paper: CR1 and CR3, complement receptor types 1 and 3; DAF, decay-accelerating factor; E, erythrocyte(s); FITC, fluorescein isothiocyanate; fMLP, N-formyl-methionyl-leucyl-phenylalanine; PNH, paroxysmal nocturnal hemoglobinuria; ZAS, zymosanactivated serum.
soluble immune complexes, neighboring cells, or foreign particles, it is believed that its physiologic function is to protect host E from damage by autologous complement (3) . This hypothesis is strengthened by observations that the complement-sensitive E from patients with paroxysmal nocturnal hemoglobinuria (PNH) are deficient in DAF (2, 4, 5) , and that incorporation of purified DAF into the membranes ofthese cells ameliorates this abnormality (5) .
Recent studies have demonstrated that DAF is also present on blood platelets, lymphocytes, mnonocytes, asid neutrophils (polymorphonuclear leukocytes [PMN] ) of normal individuals (6, 7) . Comparison in a previous study of the content of DAF in cell extracts, as determined by immunoradiometric assay, with surface DAF expression, as determined by indirect immunofluorescence using monoclonal anti-DAF antibodies and flow cytometry, suggested that PMN contain more total DAF than is present on their surface membranes (6) . These findings seemed analogous to results previously obtained for C3b and iC3b receptors (complement receptor types 1 and 3 [CR1 and CR31), which have been shown to reside predominantly in intracellular pools in unstimulated circulating PMN (8-1 1) . When the PMN are activated by chemoattractants, the intracellular CR1. and CR3 pools are rapidly translocated to the surface membrane by a process that does not require new protein synthesis (9) (10) (11) (12) . This translocation enhances the adherence and phagocytic activity of these cells as they move towards sites of infection ( 13) .
Because increased amounts of"nascent" C4b and C3b molecules are likely to be present at inflammatory sites where complement activation is proceeding at a rapid rate, host PMN at these sites may be at increased risk for lysis by autologous complement. The present investigations were undertaken to determine whether the expression of DAF increases when PMN are activated. The results indicate that the amount ofDAF expressed on the PMN surface rises at least twofold in response to complement activation products and other chemotactic stimuli. This increased DAF expression on PMN may be an important selfprotective mechanism allowing these cells to survive and function while moving towards sites of complement activation in the inflammatory milieu. The results additionally indicate that in PNH, a disorder in which PMN are susceptible to uptake of increased amounts of autologous C3b ( 14) and because they are deficient in surface DAF (6, 15) Leukocyte isolation and incubation. PMN were isolated from freshly drawn heparinized blood of normal donors and patients as described previously (9) . Briefly, the blood was layered over density gradients (17) of Percoll (Pharmacia Fine Chemicals, Piscataway, NJ) and centrifuged at 300 gat 140C for 17 min. E were removed by two cycles of lysis using ice-cold 0.2% NaCl followed by addition of 1.6% NaCl. Immunofluorescent staining andflow cytometry. Immunofluorescent staining was carried out with all steps performed at 0-4°C (9) . Briefly, after incubation, PMN were divided into aliquots of 106 cells, washed with HBSS containing 0.1% bovine serum albumin, 0.05% NaN3, and I0 M PMSF (HBSS+), and resuspended in 50 Al of the same solution.
Monoclonal antibodies were added in excess as determined in preliminary titration experiments, and the mixtures were incubated on a rotator for 30 min. Cells were washed twice and resuspended in the same solution, excess FITC-F(ab)2 anti-mouse IgG or anti-rat Igconjugate was added, and incubation continued for another 30 min. The stained cells were washed three times, then resuspended in phosphate-buffered saline containing 0.05% NaN3 and held on ice until examination in the flow cytometer.
The bound. The remaining supernatant and most of the oil were aspirated and the tube was cut. The tip containing the cell pellet was counted to determine the bound radioactivity. Specific binding was determined by subtracting the radioactivity in the pellets of tubes containing 100-fold excess of unlabeled antibody from the corresponding tubes containing '2"1-labeled antibody alone. Counts of duplicate aliiquots from each incubation were averaged and corrected back to the original total volume, and the data was analyzed by the method of Scatchard (20) using an Apple Ile computer (Cupertino, CA).
DAF contents in NP-40 extracts of PMN were determined using an immunoradiometric assay as previously described (6) . The absolute concentration of the DAF standard was established by amino acid analysis.
Results
Quantitation of surface DAF expression on isolated PMN and correlation with fluorescence measurements. In order to quantify the number of DAF molecules on the surface of PMN, increasing amounts of 1251-anti-DAF monoclonal antibody IIH6 were incubated with the cells and both total and specific binding were determined. Results of a representative experiment are shown in Fig. 1 A and the corresponding Scatchard analysis is shown in Fig. 1 B. In this study, which was performed on freshly isolated cells held in the resting state at 0C, the apparent dissociation constant was 1.6 X 10-9 M and the estimated number of sites (8, 9) . Studies of isolated PMN at 00C using anti-DAF monoclonals are shown in the left group of bars in Fig. 2 in relation to control studies using anti-CRI1 and anti-CR3 monoclonals. As can be seen, higher fluorescence on resting cells at 00C was obtained with anti-DAF than with the antibodies to either of the complement receptors. Because CR1 and DAF were stained with the same FITC-conjugate, the relative fluorescent intensities reflect the relative numbers ofeach protein, assuming one antibody molecule binds to each protein molecule (6, 9, 12) . The value obtained for DAF, 3.53±0.38, (mean±SEM, n = 7) was 2.2 times higher than that for CR1, 1 .59±0.51 in this series of determinations.
The effect oftemperature on DAF expression on the isolated PMN was evaluated next. As shown in Fig. 2 , surface DAF levels increased 1.47-fold when the cells were warmed from 0C to 370C. This increase resembled the increases in CR1 and CR3 expression which have been observed when buffy coat cells or PMN isolated by centrifugation are warmed to 370C in the absence of chemical stimuli (8) (9) (10) . In the determinations of CR1 and CR3 expression performed here in parallel to the analyses Fig. 4 , an increase in DAF expression resulted that was comparable to the increase induced by tMLP. In contrast to the fMLP effect, however, the effect of ionomycin was dependent on extracellular Ca2+ and was markedly inhibited by EDTA. These results parallel those previously reported for CR1 (21) and suggest that increased expression of DAF may similarly depend on the release of Ca2" from intracellular stores rather than on the influx of extracellular Ca2" which is also initiated by fMLP.
DAF expression on PMNfrom patients with PNH. Recent studies have shown that DAF is deficient in affected PMN of PNH patients (6, 15) . In view of the above observations that a major portion of DAF in circulating PMN resides inside the cell rather than on the membrane, we next investigated whether PNH PMN could increase their DAF expression in response to activating stimuli. FACS Analyzer histograms of the immunofluorescence of PMN of a normal donor and two PNH patients are shown in Fig. 5 . As seen in Fig. 5 A, the PMN from the normal donor appeared as a single population with respect to DAF, CR1, and CR3 staining, and the expression of all three surface proteins increased in response to stimulation with fMLP. Fig. 5 B shows parallel studies on PMN from a patient (M.W.) with type II E. Staining for DAF revealed two distinct populations of PMN, one with no fluorescence above background, and another which appeared to express a relatively normal amount of DAF in the resting state. When these cells were stimulated with fMLP, the DAF-negative population did not change while the mean fluorescence of the DAF-positive population increased from 13.9 to 20.1. When corrected by subtracting the background fluorescence, this change represented a 1.6-fold increase, approximating that shown with PMN from normal individuals (see above). In contrast to the findings for DAF, this individual's PMN appeared as one homogeneous population with regard to CR1 and CR3 expression, and all cells increased these markers normally in response to stimulation. The results with PMN from a patient (P.K.) with type III E are shown in Fig. 5 C. In distinction to patient M.W., with type II E described above, the resting PMN showed a single population with DAF fluorescence indistinguishable from background. There was little or no change in DAF expression when these cells were stimulated. As 10 ,M trifluoperazine, which inhibits calmodulin and/or protein kinase C-dependent processes (25, 26) , but not by EDTA. Further evidence suggesting a role ofCa2" is provided by the increase in DAF expression induced by ionomycin with Ca2+. There appears to be more DAF than CR1 on the surface of isolated PMN maintained at 0C as judged both by relative fluorescence and by direct-binding studies of '251-anti-DAF monoclonal antibodies. Recent studies have shown that E DAF differs from CR1 in that it is anchored to the membrane by a C-terminal glycolipid structure that is added to the DAF molecule during posttranslational processing (27) . Determination of the relationship of the intracellular pool(s) of DAF to those of CR1 and CR3 and elucidation of the precise mechanism by which DAF is translocated to the surface membrane await further study.
Although the underlying defect in PNH is not yet clarified, the deficiency ofDAF in E plays a major role in pathophysiology (1-7). Reconstitution of PNH E with DAF restores their ability to circumvent autologous C3b uptake and subsequent lysis (5) . Immunochemical analyses have demonstrated that DAF is deficieni in PMN of all PNH patients studied to date (4, 6). In the two PNH patients described in this study, this was also the case, and the percentage ofDAF-negative circulating PMN Because PMN must migrate to and function in inflammatory sites where complement consumption is proceeding at rapid rates, it seems advantageous that the expression ofDAF on their membranes should increase in response to chemoattractants. The major function of DAF is believed to be protection of the cell against damage by autologous complement. Such damage could certainly occur if increased amounts of C4b and C3b, generated by convertases on other cells and/or in the fluid phase, became deposited on the infiltrating host PMN, and served as sites for formation of additional convertase activity. This amplification is specifically inhibited by DAF. The increased expression ofDAF under these conditions may thus be important in allowing the PMN to survive and function at sites ofinfection and inflammation.
